6Vasari RS. Expanding indications for natriuretic peptides: importance of better new (research) protocols[J]. Am Heart J,2004,148(5) :734-746.
7Yoshihiko S, Temyo Y.Application of NT-proBNP and BNP measurements in care: a more discerning marker for the detection and evaluation of heart failure [J]. Eur J Heart Fail,2004,6(3) :295-300.
8Bhatia V, Nayyar P, Dhindsa S. Brain natriuretic peptide in diagnosis and treatment of heart failure[J].Postgrad Med,2003,49(2):182-185.
10Groenning BA, Nilsson JC, Sondergaard L, et al. Detection of left enlargement and impaired systolic function with plasma N-terminal probrain natriuretic peptide concentrations[ J ]. Am Heart J, 2002,143 (5) : 923-929.
2Hunt PJ, Richards AM, Nicholls MG, et al. Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment. Clin Endocrinol, 1997, 47:287 -296.
3Yeo KT , Wu AH , Apple FS, et al. Multicenter evaluation of the Roche NT-proBNP assay and comparison to the Biosite Triage BNP assay. Clin Chim Acta, 2003, 338:107-115.
4Cowie MR, Struthers AD, Wood DA, et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet, 1997, 350:1349-1353.
5McDonagh TA, Robb SD, Murdoch DR, et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet, 1998, 351:9-13.
6Pfister R, Scholz M, Wielckens K, et al. Use of NT-proBNP in routing testing and comparison to BNP. Eur J Heart Fail, 2004, 6:289 -293.
7Seino Y, Ogawa A, Yamashita T, et al. Application of NT-proBNP and BNP measurements in cardiac care: a more discerning marker for the detection and evaluation of heart failure. Eur J Heart Fail, 2004, 6:295-300.
8McCullough PA, Sandberg KR. B-type natriuretic peptide and renal disease. Heart Fail Rev, 2003, 8:355 -358.
9Richards AM , Nicholls MG , Yandle TG , et al. Plasma N-terminal pro-brain natriureitc peptide and adrenomedullin: new neurohormonal predictors of left ventriculation function and prognosis after myocardial infarction. Circulation, 1998, 97:1921-1929.
10McCullough P A,Nowak R M,McCord J,et al.B-type natriuretic peptide and clinical judgement in emergency diagnosis of heart failure:analysis from Breathing Not Properly (BNP) Multinational study[J].Circulation,2002,106(4):419-422.
7The European Society of Cardiology 2005. Guidelines for the diagnosis and treatment of chronic heart failure ( update 2005 ) [ J ]. Eur Heart J, 2005,26 ( 11 ) : 1115-1140.
8Kozdag G, Ural D, Vural A, et al. Relation between free triiodothyronine/free thyroxine ratio, echocardiographic parameters and mortality in dilated cardiomyopathy [ J ]. Eur J Heart Fail,2005,7 ( 1 ) : 113-118.
9Pingitore A, Iervasi G, Barison A, et al. Early activation of an altered thyroid hormone profile in asymptomatic or mildly symptomatic idiopathic left ventricular dysfunction [ J ]. J Card Fail,2006,12 (7) :520-526.
10Kahaly GJ, Dillmann WH. Thyroid hormone action in the heart[ J]. Endocr Rev,2005,26 ( 5 ) :704-728.
